✦ LIBER ✦

P-793 Outcome in the treatment of small cell lung cancer: A comparison between an anthracyclin-containing and a platinum-containing regimen

✍ Scribed by Santo, A.; Tassinari, D.; Genestreti, G.; Pasquini, E.; Fiorio, E.; Tamburini, E.; Consoli, F.; Terzi, A.; Ravaioli, A.; Cetto, G.

Book ID: 123189301
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 132 KB
Volume: 49
Category: Article
ISSN: 0169-5002
DOI: 10.1016/S0169-5002(05)81286-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of gemcitabine plus platinum ch

Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes

✍ Le Chevalier, T.; Scagliotti, G.; Natale, R.; Danson, S.; Rosell, R.; Stahel, R. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 313 KB

Early results of a randomized phase III

Early results of a randomized phase III trial of platinum-containing doublets versus a nonplatinum doublet in the treatment of advanced non–small cell lung cancer: European Organization for Research and Treatment of Cancer 08975

✍ Giuseppe Giaccone 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 96 KB

P-542 Carboplatin (C) and docetaxel (D)

P-542 Carboplatin (C) and docetaxel (D) in the second-line treatment of non-small cell lung cancer (NSCLC) patients pretreated with platinum-based regimens. A Phase II trial

✍ Numico, G.; Buffoni, L.; Dongiovanni, V.; Schena, M.; Fissore, C.; Fea, E.; Occe 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 175 KB

Gain of a region on 7p22.3, containing M

Gain of a region on 7p22.3, containing MAD1L1, is the most frequent event in small-cell lung cancer cell lines

✍ Bradley P. Coe; Eric H. L. Lee; Bryan Chi; Luc Girard; John D. Minna; Adi F. Gaz 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 914 KB

## Abstract Small‐cell lung cancer (SCLC) is a highly aggressive lung neoplasm, which accounts for 20% of yearly lung cancer cases. The lack of knowledge of the progenitor cell type for SCLC precludes the definition of a normal gene expression profile and has hampered the identification of gene exp

The association between the ERCC1/2 poly

The association between the ERCC1/2 polymorphisms and the clinical outcomes of the platinum-based chemotherapy in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis

✍ Yanlong Yang,Lei Xian 📂 Article 📅 2013 🏛 S. Karger AG 🌐 English ⚖ 857 KB

Preliminary results of a randomised phas

Preliminary results of a randomised phase III trial comparing four cisplatin (P)-based regimens in the treatment of locally advanced and metastatic non-small cell lung cancer (NSCLC)

✍ Costa, A; Barradas, P; Cristóvão, M; Alves, P; Melo, M.J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 111 KB